Patents by Inventor Christine Janet Martin

Christine Janet Martin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Sanglifehrin derivatives and methods for their production
    Patent number: 9271977
    Abstract: There are provided inter alia compounds of formula (I) and (II) and their use in therapy, particularly for the treatment of viral infection.
    Type: Grant
    Filed: December 20, 2011
    Date of Patent: March 1, 2016
    Assignee: NeuroVive Pharmaceutical AB
    Inventors: Steven James Moss, Matthew Alan Gregory, Barrie Wilkinson, Steven Gary Kendrew, Christine Janet Martin
  • Sanglifehrin based compounds
    Patent number: 9119853
    Abstract: There are provided inter alia compounds of formula (I) useful as cyclophilin inhibitors.
    Type: Grant
    Filed: February 9, 2011
    Date of Patent: September 1, 2015
    Assignee: Neurovive Pharmaceutical AB
    Inventors: Steven James Moss, Matthew Alan Gregory, Barrie Wilkinson, Christine Janet Martin
  • Sanglifehrin Derivatives and Methods for Their Production
    Publication number: 20140080837
    Abstract: There are provided inter alia compounds of formula (I) and (II) and their use in therapy, particularly for the treatment of viral infection.
    Type: Application
    Filed: December 20, 2011
    Publication date: March 20, 2014
    Applicant: Neurovive Pharmaceuticals AB
    Inventors: Steven James Moss, Matthew Alan Gregory, Barrie Wilkinson, Steven Gary Kendrew, Christine Janet Martin
  • Sanglifehrin Based Compounds
    Publication number: 20120295841
    Abstract: There are provided inter alia compounds of formula (I) useful as cyclophilin inhibitors.
    Type: Application
    Filed: February 9, 2011
    Publication date: November 22, 2012
    Inventors: Steven James Moss, Matthew Alan Gregory, Barrie Wilkinson, Christine Janet Martin
  • Production of polyketides and other natural products
    Patent number: 7803808
    Abstract: The present invention relates to production of polyketides and other natural products and to libraries of compounds and individual novel compounds. Therefore in aspect the present invention provides 17-desmethylrapamycin and analogues thereof, methods for their production, including recombinant strains, and isolation and uses of the compounds of the invention. In a further aspect the present invention provides for the use of 17-desmethylrapamycin and analogues thereof in the induction or maintenance of immunosuppression, the stimulation of neuronal regeneration or the treatment of cancer, B-cell malignancies, fungal infections, transplantation rejection, graft vs. host disease, autoimmune disorders, diseases of inflammation vascular disease and fibrotic diseases, and in the regulation of wound healing.
    Type: Grant
    Filed: August 11, 2005
    Date of Patent: September 28, 2010
    Assignee: Wyeth LLC
    Inventors: Matthew Alan Gregory, Christine Janet Martin
  • Production Of Polyketides And Other Natural Products
    Publication number: 20090253732
    Abstract: The present invention relates to production of polyketides and other natural products and to libraries of compounds and individual novel compounds. Therefore in aspect the present invention provides 17-desmethylrapamycin and analogues thereof, methods for their production, including recombinant strains, and isolation and uses of the compounds of the invention. In a further aspect the present invention provides for the use of 17-desmethylrapamycin and analogues thereof in the induction or maintenance of immunosuppression, the stimulation of neuronal regeneration or the treatment of cancer, B-cell malignancies, fungal infections, transplantation rejection, graft vs. host disease, autoimmune disorders, diseases of inflammation vascular disease and fibrotic diseases, and in the regulation of wound healing.
    Type: Application
    Filed: August 11, 2005
    Publication date: October 8, 2009
    Inventors: Matthew Alan Gregory, Christine Janet Martin
  • 21-DEOXYMACBECIN ANALOGUES USEFUL AS ANTITUMOR AGENTS
    Publication number: 20090209494
    Abstract: The present invention relates to 21-deoxymacbecin analogues that are useful, e.g. in the treatment of cancer, B-cell malignancies, malaria, fungal infection, diseases of the central nervous system and neurodegenerative diseases, diseases dependent on angiogenesis, autoimmune diseases or as a prophylactic pretreatment for cancer. The present invention also provides methods for the production of these compounds and their use in medicine, in particular in the treatment and or prophylaxis of cancer or B-cell malignancies.
    Type: Application
    Filed: December 22, 2006
    Publication date: August 20, 2009
    Inventors: Christine Janet Martin, Barrie Wilkinson, Sabine Gaisser, Ming-Oiang Zhang, Rose Mary Sheridan, Lesley Sarah Sheehan, Rachel Edith Lill, Mohammed Nur-E-Alam, William Alexander Vousden